Skip to main content

People

12 people
StartupArie BelldegrunHP276
Arie Belldegrun
Advisor
Allogene Therapeutics logo
Allogene Therapeutics·IPO
View Profile →
StartupDavid BondermanHP276
David Bonderman
Advisor
Allogene Therapeutics logo
Allogene Therapeutics·IPO
View Profile →
StartupDeborah MessemerHP276
Deborah Messemer
Advisor
Allogene Therapeutics logo
Allogene Therapeutics·IPO
View Profile →
StartupFranz HumerHP276
Franz Humer
Advisor
Allogene Therapeutics logo
Allogene Therapeutics·IPO
View Profile →
StartupHouman DehghaniHP276
Senior Director
Allogene Therapeutics logo
Allogene Therapeutics·IPO
View Profile →
StartupJohn DeYoungHP276
John DeYoung
Advisor
Allogene Therapeutics logo
Allogene Therapeutics·IPO
View Profile →
StartupJoshua KazamHP276
Joshua Kazam
Co-Founder
Allogene Therapeutics logo
Allogene Therapeutics·IPO
View Profile →
StartupOwen WitteHP276
Owen Witte
Advisor
Allogene Therapeutics logo
Allogene Therapeutics·IPO
View Profile →
StartupRafael AmadoHP276
Rafael Amado
Executive Vice President, Head of R&D & Chief medical Officer
Allogene Therapeutics logo
Allogene Therapeutics·IPO
View Profile →
StartupRobert ToHP276
Robert To
Associate Director, External Testing Oversight
Allogene Therapeutics logo
Allogene Therapeutics·IPO
View Profile →
StartupScott NavinsHP276
Scott Navins
Treasurer
Allogene Therapeutics logo
Allogene Therapeutics·IPO
View Profile →
StartupZachary RobertsHP276
Zachary Roberts
Executive Vice President of Research & Development
Allogene Therapeutics logo
Allogene Therapeutics·IPO
View Profile →